Evidence map›Paper›PMID 39325679›Full record

ArticleNanomedicine (London, England)2024

Niosomes loaded with gold nanoparticles for enhanced radiation therapy in lung cancer.

Ramezan Ali Taheri, Hamidreza Fathi, Ali Sharafi, Morteza Mirzaei, Shima Jafari, Mohammad Hasan Darvishi

Abstract read
In one paragraph

Article in Nanomedicine (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ramezan Ali TaheriNanobiotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.ORCID 0000-0003-1394-6412
Hamidreza FathiDepartment of Virology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.ORCID 0000-0002-2152-0692
Ali SharafiZanjan Pharmaceutical Biotechnology Research Center, Zanjan University of Medical Sciences, Zanjan, Iran.ORCID 0000-0002-6012-1424
Morteza MirzaeiApplied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.ORCID 0000-0001-5568-2422
Shima JafariStudent Research Committee, Baqiyatallah University of Medical Sciences, Tehran, Iran.ORCID 0009-0005-1772-3891
Mohammad Hasan DarvishiNanobiotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.ORCID 0000-0001-5702-3332

Funding

Baqiyatallah University of Medical Sciences 401000225
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ApoptosisGoldLiposomesLung NeoplasmsMetal NanoparticlesA549 CellsCell ProliferationCell SurvivalHumansNickelParticle SizeX-Ray TherapyGoldLiposomesNickelnickel monoxidecombination therapygold nanoparticleslung cancerniosomesradiation therapyradiosensitizer

Identifiers

PMID39325679
PMCPMC11487956

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.